Coastwise Capital Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
3,206
+165
+5% +$56.5K 0.67% 39
2026
Q1
$1.07M Buy
3,041
+20
+0.7% +$7.13K 0.59% 40
2025
Q4
$989K Buy
3,021
+188
+7% +$59.6K 0.49% 46
2025
Q3
$799K Buy
2,833
+41
+1% +$11.9K 0.56% 47
2025
Q2
$779K Buy
2,792
+165
+6% +$46.7K 0.62% 42
2025
Q1
$818K Buy
2,627
+315
+14% +$93K 0.69% 42
2024
Q4
$603K Buy
2,312
+65
+3% +$19.3K 0.48% 53
2024
Q3
$724K Buy
2,247
+105
+5% +$34.3K 0.6% 42
2024
Q2
$669K Sell
2,142
-201
-9% -$59K 0.64% 42
2024
Q1
$666K Sell
2,343
-396
-14% -$116K 0.62% 46
2023
Q4
$789K Sell
2,739
-34
-1% -$9.26K 0.8% 38
2023
Q3
$745K Buy
2,773
+1,020
+58% +$255K 0.85% 38
2023
Q2
$389K Buy
1,753
+102
+6% +$23.7K 0.44% 63
2023
Q1
$399K Buy
1,651
+304
+23% +$74.6K 0.46% 63
2022
Q4
$354K Buy
1,347
+192
+17% +$51.5K 0.42% 67
2022
Q3
$260K Sell
1,155
-95
-8% -$23K 0.41% 77
2022
Q2
$304K Sell
1,250
-293
-19% -$71.8K 0.37% 72
2022
Q1
$373K Buy
+1,543
New +$355K 0.46% 68

Other funds holding AMGN

Coastwise Capital Group's AMGN Position: Q2 2026 in Review

Coastwise Capital Group increased its Amgen (AMGN) stake by 5.4% in Q2 2026, buying an estimated $56.5K and bringing the position to 3,206 shares worth $1.16M. The position accounts for 0.67% of the portfolio, ranked #39.

Coastwise Capital Group first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Coastwise Capital Group held 3,206 shares of Amgen worth $1.16M as of Q2 2026.
  • Coastwise Capital Group bought 165 Amgen shares in Q2 2026, an estimated $56.5K.
  • Amgen made up 0.67% of Coastwise Capital Group's portfolio in Q2 2026, its #39 holding.
  • Coastwise Capital Group first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.